All Updates

All Updates

icon
Filter
M&A
Funding
BehaVR and OxfordVR merge and raise USD 13 million
Extended Reality
Dec 14, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Extended Reality

Extended Reality

Dec 14, 2022

BehaVR and OxfordVR merge and raise USD 13 million

M&A
Funding

  • Virtual reality (VR) based mental health providers BehaVR and OxfordVR merged to form the largest virtual reality healthcare delivery platform. The providers will merge and operate under BehaVR’s brand with BehaVR's founder CEO Aaron Gani leading the company, with Dr. Daniel Freeman, OxfordVR's founder, being a part of the leadership team. 

  • The merged entities raised USD 13 million in a Series B funding round co-led by Oxford Science Enterprises and Optum Ventures, along with participation from other venture capital firms. The funds raised will be used to support the merger of the two entities.

  • The combined entity will continue to provide BehvaVR’s clinically validated and VR-based treatments for mental and behavioral health conditions and chronic diseases while including OxfordVR’s FDA-approved automated cognitive-behavioral VR therapy “gameChange.” 

  • BehaVR is a virtual reality (VR)-based mental health startup that provides digital therapy to clients through virtual reality, cloud computing, and machine learning. It allows VR sessions to be personalized and engaging through patient experience logs and responses being captured and analyzed.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.